Unknown NA INTERVENTIONAL 2-arm NCT03811938

Ablation of Low Voltage Regions in Persistent Atrial Fibrillation (ABLOVO-AF)

Catheter ABlation of Low Voltage Regions in the Treatment of Persistent Atrial Fibrillation (ABLOVO-AF Study)

Sponsor: Abbott

Conditions Persistent Atrial Fibrillation

Interventions Low voltage ablation Pulmonary Vein Isolation

Updated 5 times since 2019 Last updated: Jan 28, 2019 Started: Aug 24, 2017 Primary completion: Jun 30, 2020 Completion: Jun 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Persistent Atrial Fibrillation and is currently ongoing. Abbott leads this study, which shows 5 recorded versions since 2017 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2021 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Jan 2021 — Feb 2021 [monthly]

Recruiting NA
Feb 2019 — Jan 2021 [monthly]

Recruiting NA

First recorded

Aug 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott
Imperial College London

Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom